DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD)
Clinical trial NCT05966064 · RECRUITING
Trial details
- NCT number
- NCT05966064
- Sponsor
- Natasha Appelman-Dijkstra
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-13
- Primary completion
- 2027-12-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.